By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Derma Sciences, Inc. 

214 Carnegie Center
Suite 100
Princeton  New Jersey  08540  U.S.A.
Phone: 609-514-4744 Fax: 609-514-0502




Company News
Derma Sciences (DSCI) Provides 2015 Preliminary Net Sales And Introduces 2016 Financial Guidance 1/7/2016 12:14:06 PM
Derma Sciences (DSCI) CEO Edward Quilty Resigns Following Trial Failure 12/21/2015 7:36:48 AM
Derma Sciences (DSCI) To Participate In The 27th Annual Piper Jaffray Healthcare Conference 11/25/2015 8:47:10 AM
Derma Sciences (DSCI) To Participate In The Canaccord Genuity 2015 Medical Technology & Diagnostics Forum 11/16/2015 11:05:03 AM
Derma Sciences (DSCI) Exploring Sale After Stopping Development of Its Only Drug 11/13/2015 5:59:52 AM
Derma Sciences (DSCI) To Hold Conference Call On November 12 To Discuss Data Monitoring Committee Pre-Specified Interim Analysis Of The Aclerastide Phase 3 Trials 11/12/2015 11:20:43 AM
Derma Sciences (DSCI)'s Phase III Aclerastide Study Terminated Due to Ineffectiveness 11/12/2015 5:51:54 AM
Derma Sciences, Inc. (DSCI) Reports Third Quarter 2015 Financial Results 11/9/2015 1:51:29 PM
Derma Sciences, Inc. (DSCI) To Hold Third Quarter Financial Results Conference Call On November 9th 11/3/2015 11:07:03 AM
Derma Sciences, Inc. (DSCI) Reports Second Quarter Financial Results 8/10/2015 10:37:16 AM